$BNGO SEC Filings

Filed On	Filing
27 Oct 2026	S-1
19 Oct 2026	SCHEDULE 13G
14 Sep 2026	8-K: Regulation FD Disclosure September 14, 2026 Albert Luderer, PhD Chairman and Interim CEO Bionano
09 Sep 2026	Form 4: Luderer Albert, Director Bought 4,000 shares ($4.84K)
21 Aug 2026	Form 4: Luderer Albert, Director Bought 4,000 shares ($4.86K)
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
05 Aug 2026	Form 4: Adamchak Mark, Principal Accounting Officer Granted 5,000 Stock Option (Right to Buy)
05 Aug 2026	Form 4: Dixon Jonathan V., General Counsel Granted 15,000 Stock Option (Right to Buy)
05 Aug 2026	Form 4: Oldakowski Mark, Chief Operating Officer Granted 15,000 Stock Option (Right to Buy)
05 Aug 2026	Form 4: Hastie Alex Reid, Chief Scientific Officer Granted 54,000 Stock Option (Right to Buy)
05 Aug 2026	Form 3: Oldakowski Mark, Chief Operating Officer
05 Aug 2026	Form 3: Adamchak Mark, Principal Accounting Officer
05 Aug 2026	Form 3: Hastie Alex Reid, Chief Scientific Officer
05 Aug 2026	Form 3: Dixon Jonathan V., General Counsel
30 Jul 2026	Form 3: Hastie Alex Reid, Chief Scientific Officer Holds 63 shares of Common Stock
24 Jun 2026	8-K: Other Events
05 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
03 Jun 2026	Form 4: Dixon Jonathan V., GENERAL COUNSEL Gave up 24 shares to cover exercise price or tax ($31.2)

Comments